NASH Pharmaceuticals

Nash Pharmaceuticals Inc is a privately held drug development company focusing on developing repurposed therapeutic drugs. The company has developed data that supports the advancement of up to 7 drug candidates into phase II trials in the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD).

sorry, we didn't find this page